For example, BCL2 family are central regulators of apoptosis, and up-regulation of BCL2 has been shown to lead to tumor development and progression as well as resistance to cancer therapy (Lindner et al., 2017; Perini et al., 2018; Diaz-Flores et al., 2019). This evidence concerns the gene BCL2 and neoplasm.